☰

Joseph M. Cantor, Ph.D. - Publications

Affiliations: 
2005 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Immunology
Tree Info Grants Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Ablack JN, Ortiz J, Bajaj J, Trinh K, Lagarrigue F, Cantor JM, Reya T, Ginsberg MH. MARCH Proteins Mediate Responses to Antitumor Antibodies. Journal of Immunology (Baltimore, Md. : 1950). PMID 33077644 DOI: 10.4049/jimmunol.1901245  0.43
2018 Klann JE, Kim SH, Remedios KA, He Z, Metz PJ, Lopez J, Tysl T, Olvera JG, Ablack JN, Cantor JM, Boland BS, Yeo G, Zheng Y, Lu LF, Bui JD, et al. Integrin Activation Controls Regulatory T Cell-Mediated Peripheral Tolerance. Journal of Immunology (Baltimore, Md. : 1950). PMID 29703862 DOI: 10.4049/Jimmunol.1800112  0.518
2017 Lagarrigue F, Gertler FB, Ginsberg MH, Cantor JM. Cutting Edge: Loss of T Cell RIAM Precludes Conjugate Formation with APC and Prevents Immune-Mediated Diabetes. Journal of Immunology (Baltimore, Md. : 1950). PMID 28348273 DOI: 10.4049/Jimmunol.1601743  0.508
2016 Bajaj J, Konuma T, Lytle NK, Kwon HY, Ablack JN, Cantor JM, Rizzieri D, Chuah C, Oehler VG, Broome EH, Ball ED, van der Horst EH, Ginsberg MH, Reya T. CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia. Cancer Cell. 30: 792-805. PMID 27908736 DOI: 10.1016/J.Ccell.2016.10.003  0.454
2016 Liao Z, Cantor JM. Endothelial Cells Require CD98 for Efficient Angiogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 27687603 DOI: 10.1161/Atvbaha.116.308335  0.482
2016 Abplanalp WT, Conklin DJ, Cantor JM, Ginsberg MH, Wysoczynski M, Bhatnagar A, O'Toole TE. Enhanced Integrin α4β1-Mediated Adhesion Contributes to a Mobilization Defect of Endothelial Progenitor Cells in Diabetes. Diabetes. PMID 27495221 DOI: 10.2337/Db16-0634  0.344
2015 Ablack JN, Cantor JM, Metz PJ, Chang JT, Ginsberg MH. Ubiquitination of CD98 limits cell proliferation and clonal expansion. Journal of Cell Science. PMID 26493331 DOI: 10.1242/Jcs.178129  0.52
2015 Cantor JM, Rose DM, Slepak M, Ginsberg MH. Fine-tuning Tumor Immunity with Integrin Trans-regulation. Cancer Immunology Research. 3: 661-7. PMID 25600437 DOI: 10.1158/2326-6066.Cir-13-0226  0.466
2015 Hayes GM, Chinn L, Cantor JM, Cairns B, Levashova Z, Tran H, Velilla T, Duey D, Lippincott J, Zachwieja J, Ginsberg MH, H van der Horst E. Antitumor activity of an anti-CD98 antibody. International Journal of Cancer. Journal International Du Cancer. 137: 710-20. PMID 25556716 DOI: 10.1002/Ijc.29415  0.427
2014 Cantor JM. CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis. Journal of Neuroimmunology. 274: 230-3. PMID 25002078 DOI: 10.1016/J.Jneuroim.2014.06.015  0.397
2013 Hayes GM, Chinn L, Cantor JM, Velilla T, Ginsberg MH, van der Horst EH. IGN523: A Therapeutic Anti-CD98 Antibody With Multiple Mechanisms Of Action Demonstrates Anti-Tumor Efficacy Blood. 122: 1462-1462. DOI: 10.1182/Blood.V122.21.1462.1462  0.48
2012 Cantor JM, Ginsberg MH. CD98 at the crossroads of adaptive immunity and cancer. Journal of Cell Science. 125: 1373-82. PMID 22499670 DOI: 10.1242/Jcs.096040  0.454
2011 Cantor J, Slepak M, Ege N, Chang JT, Ginsberg MH. Loss of T cell CD98 H chain specifically ablates T cell clonal expansion and protects from autoimmunity. Journal of Immunology (Baltimore, Md. : 1950). 187: 851-60. PMID 21670318 DOI: 10.4049/Jimmunol.1100002  0.606
2009 Cantor J, Browne CD, Ruppert R, Féral CC, Fässler R, Rickert RC, Ginsberg MH. CD98hc facilitates B cell proliferation and adaptive humoral immunity. Nature Immunology. 10: 412-9. PMID 19270713 DOI: 10.1038/Ni.1712  0.413
2008 Cantor JM, Ginsberg MH, Rose DM. Integrin-associated proteins as potential therapeutic targets. Immunological Reviews. 223: 236-51. PMID 18613840 DOI: 10.1111/J.1600-065X.2008.00640.X  0.307
2007 Cantor J, Haskins K. Recruitment and activation of macrophages by pathogenic CD4 T cells in type 1 diabetes: evidence for involvement of CCR8 and CCL1. Journal of Immunology (Baltimore, Md. : 1950). 179: 5760-7. PMID 17947648 DOI: 10.4049/Jimmunol.179.9.5760  0.672
2006 Cantor J, Haskins K. Interactions of macrophages and T cells in autoimmune diabetes Drug Discovery Today: Disease Mechanisms. 3: 381-385. DOI: 10.1016/J.Ddmec.2006.09.009  0.656
2006 Cantor J, Haskins K. OR.30. Recruitment and Activation of Macrophages in the Pancreas After Adoptive Transfer By Diabetogenic CD4 Th1 T-Cells Involves Interaction of CCL1 and CCR8 Clinical Immunology. 119: S15. DOI: 10.1016/J.Clim.2006.04.032  0.646
2005 Cantor J, Haskins K. Effector function of diabetogenic CD4 Th1 T cell clones: a central role for TNF-alpha. Journal of Immunology (Baltimore, Md. : 1950). 175: 7738-45. PMID 16301684 DOI: 10.4049/Jimmunol.175.11.7738  0.66
Show low-probability matches.